Onconetix, Inc. Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change
Onconetix, Inc. (ONCO) reported Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change of -$18.63 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanOtherChanges · last filed 2025-08-14
- Onconetix, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2025-06-30 was $62.37K.
- Onconetix, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for the quarter ending 2025-03-31 was -$81.00K.
- Onconetix, Inc. defined benefit plan, benefit obligation, increase (decrease) for other change for fiscal 2024 was -$37.73K.
| Period end | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 3 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 6 month | Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change 12 month |
|---|---|---|---|
| 2025-06-30 | $62.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$18.63K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$81.00K 10-Q · filed 2025-06-12 | ||
| 2024-12-31 | -$37.73K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |